The store will not work correctly when cookies are disabled.
3-((3,4-Dimethoxyphenyl)amino-4-((2-methoxyphenyl)amino)-1H-pyrrole-2,5-dione
ID: ALA4876004
PubChem CID: 164626816
Max Phase: Preclinical
Molecular Formula: C19H18N2O5
Molecular Weight: 354.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(NC2=C(c3ccccc3OC)C(=O)NC2=O)cc1OC
Standard InChI: InChI=1S/C19H18N2O5/c1-24-13-7-5-4-6-12(13)16-17(19(23)21-18(16)22)20-11-8-9-14(25-2)15(10-11)26-3/h4-10H,1-3H3,(H2,20,21,22,23)
Standard InChI Key: XNHQSWIDSXSZBR-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
11.4479 -18.4643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2651 -18.4643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5194 -17.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8565 -17.2054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1977 -17.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0234 -19.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2041 -19.1427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7791 -19.8412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1722 -20.5601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9947 -20.5760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4161 -19.8768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7446 -19.1260 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5579 -19.1256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9631 -19.8320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7756 -19.8320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1828 -19.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7714 -18.4204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9602 -18.4239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2970 -17.4361 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4204 -17.4354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8123 -18.4255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9954 -18.4062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0000 -19.1255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4098 -19.8324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1842 -20.5397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0014 -20.5397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
6 1 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
3 19 2 0
5 20 2 0
7 21 1 0
21 22 1 0
16 23 1 0
23 24 1 0
15 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.36 | Molecular Weight (Monoisotopic): 354.1216 | AlogP: 2.19 | #Rotatable Bonds: 6 |
Polar Surface Area: 85.89 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.55 | CX Basic pKa: ┄ | CX LogP: 1.47 | CX LogD: 1.47 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.77 | Np Likeness Score: -0.20 |
References
1. Serafim RAM, Sorrell FJ, Berger BT, Collins RJ, Vasconcelos SNS, Massirer KB, Knapp S, Bennett J, Fedorov O, Patel H, Zuercher WJ, Elkins JM.. (2021) Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold., 64 (18.0): [PMID:34463505] [10.1021/acs.jmedchem.0c01579] |